Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-06-12

Camp4 Therapeutics Corp (CAMP)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$3,327,238
Josh Mandel-Brehm total, FY2025
CEO pay percentile vs peers
CEO-to-median pay ratio
Say-on-pay support, latest vote
Companies that benchmark against CAMP
No companies currently name CAMP as a compensation peer in their most recent disclosure.

This is the complete answer, not a partial one — the list is never padded.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Josh Mandel-Brehm$600,000$0$0$2,430,988$285,750$0$10,500$3,327,238
President and Chief Executive Officer
Kelly Gold465,000001,112,042178,095091,5961,846,733
Chief Financial Officer
Yuri Maricich500,000001,112,042191,500010,5001,814,042
Chief Medical Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Josh Mandel-Brehm$3,327,238$2,294,985+1,032,253
Kelly Gold1,846,7331,310,523+536,210
Yuri Maricich1,814,0422,521,505−707,463

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Richard Young, PhDDirector2026-06-10A28,000$0$0Derivative, Class A CommonForm 4 ↗
Douglas Williams, PhDDirector2026-06-10A28,00000Derivative, Class A CommonForm 4 ↗
Andrew J. SchwabDirector2026-06-10A28,00000Derivative, Class A CommonForm 4 ↗
Steven HoltzmanDirector2026-06-10A28,00000Derivative, Class A CommonForm 4 ↗
Murray StewartDirector2026-06-10A28,00000Derivative, Class A CommonForm 4 ↗
Amir NashatDirector2026-06-10A28,00000Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Kelly GoldOPTION2025-12-11190,000
Yuri MaricichOPTION2024-08-27132,886
Josh Mandel-BrehmOPTION2024-03-2744,579
Kelly GoldOPTION2025-04-0180,000
Kelly GoldOPTION2024-03-2744,579
Josh Mandel-BrehmOPTION2025-12-11425,000
Josh Mandel-BrehmOPTION2025-04-01160,000
Yuri MaricichOPTION2025-04-0180,000
Yuri MaricichOPTION2025-12-11190,000
03b

Vehicle mix — grant-date fair value by award type

Grant-level vehicle detail not disclosed.

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Josh Mandel-BrehmOption425,0006.01
Yuri MaricichOption88,58112.79
Kelly GoldRSU6,06010,000
Josh Mandel-BrehmRSU6,06010,000
Yuri MaricichRSU6,06010,000
Kelly GoldOption88,58112.79
Josh Mandel-BrehmOption130,0013.86
Kelly GoldOption65,0013.86
Kelly GoldOption17,3348.41
Kelly GoldOption25,0719.08
Kelly GoldOption190,0006.01
Josh Mandel-BrehmOption4,1795.5
Yuri MaricichOption65,0013.86
Yuri MaricichOption190,0006.01
Josh Mandel-BrehmOption64,0618.41
Kelly GoldOption9185.5
Josh Mandel-BrehmOption25,0719.08
05

Incentive-plan design — the Compensation Discussion & Analysis

Our executive compensation program is designed to attract, retain and reward key employees, to incentivize them based on the achievement of key performance goals, and to align their interests with the interests of our stockholders.

CEO STI target (% of salary)50%
CEO LTI target (% of salary)
Independent consultantAlpine
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
07

CEO pay ratio

Ratio (CEO : median employee)
CEO total compensation
Median employee compensation
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Steven HoltzmanIndependent · Compensation (Chair) · Nominating/Governance (Chair)$78,750$0$10,359$0$75,000$164,109
Richard Young, PhDIndependent · Compensation46,556010,3590100,000156,915
Douglas Williams, PhDIndependent · Board Chair · Audit48,302072,4210120,723
Murray Stewart, DM FRCPIndependent · Nominating/Governance36,172072,4210108,593
Michael HigginsIndependent · Audit (Chair) · Compensation · Not standing for re-election60,000010,359070,359
Paula Ragan, PhDIndependent · Departed during FY37,500010,359047,859
Ravi Thadhani, MD, MPHIndependent · Departed during FY33,750010,359044,109
James BoylanIndependent · Departed during FY8,611010,359018,970
Andrew J. SchwabIndependent · Audit2,333010,359012,692
Amir Nashat, ScDIndependent · Nominating/Governance1,556010,359011,915
Josh Mandel-BrehmEmployee director00000
Michael MacLeanIndependent · Audit · Compensation · Newly elected000000
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer$10,359
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)15,000 / 10,000 / 10,000
Stock ownership guideline
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$353,530
Equity awards (grant-date value)$0
All other compensation$175,000
Total cost of the board$528,530

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Camp4 Therapeutics Corp2025Josh Mandel-Brehm$600,000$0$2,430,988$285,750$3,327,238

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Josh Mandel-BrehmDEF 14A2026-04-230001736730-26-000026Section “Summary Compensation Table”. As printed: 3,327,238. Filing ↗machine: r2 · c36 · span 177042–177051
2Section 01, Kelly GoldDEF 14A2026-04-230001736730-26-000026Section “Summary Compensation Table”. As printed: 1,846,733. Filing ↗machine: r4 · c36 · span 182463–182472
3Section 01, Yuri MaricichDEF 14A2026-04-230001736730-26-000026Section “Summary Compensation Table”. As printed: 1,814,042. Filing ↗machine: r6 · c36 · span 187834–187843
4Section 03, Kelly Gold OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 211199–211206
5Section 03, Yuri Maricich OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 211745–211752
6Section 03, Josh Mandel-Brehm OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 208710–208716
7Section 03, Kelly Gold OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 210903–210909
8Section 03, Kelly Gold OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 208710–208716
9Section 03, Josh Mandel-Brehm OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 198196–198203
10Section 03, Josh Mandel-Brehm OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 209115–209122
11Section 03, Yuri Maricich OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 210903–210909
12Section 03, Yuri Maricich OPTIONDEF 14A2026-04-230001736730-26-000026Section “EXECUTIVE AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: span 211199–211206
13Section 07, pay ratio10-K2026-03-050001736730-26-000016Section “CEO Pay Ratio”. As printed: —. Filing ↗
14Section 08, Steven HoltzmanDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 164,109. Filing ↗machine: t7 · r2 · c12 · span 265056–265063
15Section 08, Richard Young, PhDDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 156,915. Filing ↗machine: t7 · r3 · c12 · span 267390–267397
16Section 08, Douglas Williams, PhDDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 120,723. Filing ↗machine: t7 · r4 · c12 · span 269536–269543
17Section 08, Murray Stewart, DM FRCPDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 108,593. Filing ↗machine: t7 · r5 · c12 · span 271684–271691
18Section 08, Michael HigginsDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 70,359. Filing ↗machine: t7 · r6 · c12 · span 273824–273830
19Section 08, Paula Ragan, PhDDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 47,859. Filing ↗machine: t7 · r7 · c12 · span 275964–275970
20Section 08, Ravi Thadhani, MD, MPHDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 44,109. Filing ↗machine: t7 · r8 · c12 · span 278110–278116
21Section 08, James BoylanDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 18,970. Filing ↗machine: t7 · r9 · c12 · span 280245–280251
22Section 08, Andrew J. SchwabDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 12,692. Filing ↗machine: t7 · r10 · c12 · span 282384–282390
23Section 08, Amir Nashat, ScDDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 11,915. Filing ↗machine: t7 · r11 · c12 · span 284523–284529
24Section 08, Josh Mandel-BrehmDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 0. Filing ↗
25Section 08, Michael MacLeanDEF 14A2026-04-230001736730-26-000026Section “Director Compensation”. As printed: 0. Filing ↗
26Section 02, Richard Young, PhD 2026-06-10Form 42026-06-120001628280-26-042862Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Douglas Williams, PhD 2026-06-10Form 42026-06-120001628280-26-042863Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, Andrew J. Schwab 2026-06-10Form 42026-06-120001628280-26-042861Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Steven Holtzman 2026-06-10Form 42026-06-120001628280-26-042860Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Murray Stewart 2026-06-10Form 42026-06-120001628280-26-042859Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Amir Nashat 2026-06-10Form 42026-06-120001628280-26-042858Insider equity transaction reported since the proxy statement. Filing ↗
32Section 01 trend, Δ column (computed)ComputedcomputedΔ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
33Section 09b board cost (computed)ComputedcomputedCash 353,530 + equity 0 + all other 175,000 = 528,530, summed across the director compensation table rows.machine: formula: Σ = 528,530
34Camp4 Therapeutics Corp (subject), Section 10b CEO totalDEF 14A2026-04-230001736730-26-000026CEO total compensation as printed in Camp4 Therapeutics Corp's own proxy. As printed: 3,327,238. Filing ↗machine: r2 · c36 · span 177042–177051